Balaji Prasad
Stock Analyst at Barclays
(0.91)
# 2241
Out of 5,370 analysts
167
Total ratings
38.84%
Success rate
-1.70%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
EOLS Evolus | Maintains: Overweight | 22 25 | 9.93 | 151.76% | 8 | Mar 5, 2025 | |
AMRX Amneal Pharmaceutica... | Maintains: Overweight | 10 11 | 8.09 | 35.97% | 5 | Mar 3, 2025 | |
PCRX Pacira BioSciences | Maintains: Overweight | 17 24 | 24.29 | -1.19% | 9 | Feb 28, 2025 | |
VTRS Viatris | Maintains: Underweight | 12 9 | 8.99 | 0.11% | 8 | Feb 28, 2025 | |
JAZZ Jazz Pharmaceuticals | Maintains: Overweight | 190 200 | 109.64 | 82.42% | 7 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 20 19 | 14.01 | 35.62% | 13 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 62 60 | 41.19 | 45.67% | 5 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 242 244 | 164.2 | 48.6% | 15 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 26 24 | 10.21 | 135.06% | 2 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 20 22 | 24.69 | -10.9% | 8 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 481 520 | 528.44 | -1.6% | 9 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 28 26 | 17.5 | 48.57% | 12 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 3 | n/a | n/a | 9 | Dec 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 150 160 | 114.78 | 39.4% | 15 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 18 17 | 15.69 | 8.35% | 13 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 22 18 | 9.35 | 92.51% | 5 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 8 7 | 0.78 | 797.44% | 7 | Oct 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 3 10 | 3.67 | 172.48% | 2 | Oct 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 3 2 | n/a | n/a | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 26 21 | n/a | n/a | 4 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 2 1 | n/a | n/a | 3 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 10 | n/a | n/a | 4 | Aug 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 5 3 | n/a | n/a | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 8 | n/a | n/a | 1 | Mar 25, 2020 |